Dassie et al. demonstrated that an RNA aptamer targeting PSMA (A9g; 43-nt) inhibits the enzymatic activity of PSMA, reducing prostate cancer cell migration and invasiveness in vitro [169]. The gene discussed is FOLH1; the disease is prostate cancer.